2013 ACR/ARHP Annual Meeting

October 25-30, 2013. San Diego, CA.

View by Title View Sessions

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 94

Smoking and The Risk For Incident Gouty Arthritis
Abstract Number: 2512

Smoking Is Associated With More Severe Skin Disease In Subjects With Moderate To Severe Systemic Lupus Erythematosus (SLE)
Abstract Number: 2439

Smoking Was Not Associated With Response To Adalimumab Therapy In Patients With Non-Radiographic Axial Spondyloarthritis
Abstract Number: 1151

Snapin Is Required For Functional Autophagy and Is Critical For Monocyte To Macrophage Differentiation
Abstract Number: 2515

Social Capital: A Novel Platform For Understanding Social Determinants Of Health In Systemic Lupus Erythematosus
Abstract Number: 2115

Social Networks and Hip Replacement Outcomes In Rheumatoid Arthritis and Osteoarthritis
Abstract Number: 1051

Sociodemographic, Health System, and Community Characteristics Associated With Initiation Of Biological Dmards In RA
Abstract Number: 2356

Soluble Interleukin-2 Receptor Levels and The CD4/CD8 Ratio As Predictors Of The Efficacy Of Abatacept In Biologics-naïve Rheumatoid Arthritis Patients
Abstract Number: 1845

Soluble Type I Interferon Receptor 2 Is Elevated By Interferon Treatment and In Certain Autoimmune Diseases
Abstract Number: 1083

Something Ventured, Something Gained: Alternative Therapies For FMS and RA
Abstract Number: 979

Southern Hemisphere Educational Partnership For Pediatric Arthritis and Rheumatological Diseases (SHEPPARD): An International Educational Program
Abstract Number: 1093

SPA Therapy In The Treatment Of Chronic Shoulder PAIN Due To Rotator Cuff Tendinopathy: Rotatherm, A Large Randomized Multicentre Trial
Abstract Number: 2230

Specific Angiotensin Type II Receptor Stimulation Attenuates Collagen-Induced Arthritis Via Enhancement Of FoxP3 Regulatory T Cells
Abstract Number: 27

Specificity Of Autoantibodies In Patients With Rheumatologic Inflammatory Syndrome Following Mineral Oil Injections Is Similar To Those In Mice With Adjuvant Mineral Oil-Induced Autoimmunity
Abstract Number: 2182

Spectrum Of Musculoskeletal Inpatient Diagnoses At The Largest Pediatric Center In East Africa In 2011

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].